- Home
- CYCC vs DOMH Comparison
CYCC vs DOMH Comparison
Compare CYCC & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- DOMH
- Stock Information
- Founded
- CYCC 1992
- DOMH 1967
- Country
- CYCC Malaysia
- DOMH United States
- Employees
- CYCC N/A
- DOMH 29
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- CYCC Health Care
- DOMH Health Care
- Exchange
- CYCC Nasdaq
- DOMH Nasdaq
- Market Cap
- CYCC 47.6M
- DOMH 68.4M
- IPO Year
- CYCC N/A
- DOMH N/A
- Fundamental
- Price
- CYCC $0.35
- DOMH $5.25
- Analyst Decision
- CYCC Strong Buy
- DOMH
- Analyst Count
- CYCC 1
- DOMH 0
- Target Price
- CYCC $11.00
- DOMH N/A
- AVG Volume (30 Days)
- CYCC 7.1M
- DOMH 192.2K
- Earning Date
- CYCC 05-13-2025
- DOMH 04-15-2025
- Dividend Yield
- CYCC 43.71%
- DOMH 6.09%
- EPS Growth
- CYCC N/A
- DOMH N/A
- EPS
- CYCC N/A
- DOMH N/A
- Revenue
- CYCC $43,000.00
- DOMH $18,146,000.00
- Revenue This Year
- CYCC $137.21
- DOMH N/A
- Revenue Next Year
- CYCC N/A
- DOMH N/A
- P/E Ratio
- CYCC N/A
- DOMH N/A
- Revenue Growth
- CYCC N/A
- DOMH 789.95
- 52 Week Low
- CYCC $0.17
- DOMH $0.83
- 52 Week High
- CYCC $4.00
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- CYCC 65.97
- DOMH 57.74
- Support Level
- CYCC $0.23
- DOMH $4.40
- Resistance Level
- CYCC $0.30
- DOMH $5.72
- Average True Range (ATR)
- CYCC 0.06
- DOMH 0.41
- MACD
- CYCC 0.01
- DOMH 0.17
- Stochastic Oscillator
- CYCC 68.57
- DOMH 76.73
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.